1. Home
  2. ORGO vs HELE Comparison

ORGO vs HELE Comparison

Compare ORGO & HELE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORGO
  • HELE
  • Stock Information
  • Founded
  • ORGO 1985
  • HELE 1968
  • Country
  • ORGO United States
  • HELE United States
  • Employees
  • ORGO N/A
  • HELE N/A
  • Industry
  • ORGO Biotechnology: Pharmaceutical Preparations
  • HELE Home Furnishings
  • Sector
  • ORGO Health Care
  • HELE Consumer Discretionary
  • Exchange
  • ORGO Nasdaq
  • HELE Nasdaq
  • Market Cap
  • ORGO 539.1M
  • HELE 474.4M
  • IPO Year
  • ORGO N/A
  • HELE N/A
  • Fundamental
  • Price
  • ORGO $5.14
  • HELE $18.78
  • Analyst Decision
  • ORGO Buy
  • HELE Hold
  • Analyst Count
  • ORGO 3
  • HELE 2
  • Target Price
  • ORGO $8.00
  • HELE $24.00
  • AVG Volume (30 Days)
  • ORGO 3.1M
  • HELE 768.1K
  • Earning Date
  • ORGO 11-06-2025
  • HELE 01-07-2026
  • Dividend Yield
  • ORGO N/A
  • HELE N/A
  • EPS Growth
  • ORGO N/A
  • HELE N/A
  • EPS
  • ORGO N/A
  • HELE N/A
  • Revenue
  • ORGO $465,218,000.00
  • HELE $1,820,033,000.00
  • Revenue This Year
  • ORGO $2.51
  • HELE N/A
  • Revenue Next Year
  • ORGO $25.45
  • HELE $2.45
  • P/E Ratio
  • ORGO N/A
  • HELE N/A
  • Revenue Growth
  • ORGO 2.24
  • HELE N/A
  • 52 Week Low
  • ORGO $2.61
  • HELE $17.01
  • 52 Week High
  • ORGO $7.08
  • HELE $75.68
  • Technical
  • Relative Strength Index (RSI)
  • ORGO 50.25
  • HELE 46.94
  • Support Level
  • ORGO $5.09
  • HELE $18.44
  • Resistance Level
  • ORGO $5.83
  • HELE $19.74
  • Average True Range (ATR)
  • ORGO 0.50
  • HELE 0.91
  • MACD
  • ORGO -0.08
  • HELE 0.20
  • Stochastic Oscillator
  • ORGO 3.02
  • HELE 53.78

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

About HELE Helen of Troy Limited

Helen Of Troy Ltd is a consumer products company offering creative products and solutions for its customers through a diversified portfolio of brands. It has two operating segments: Home and Outdoor segment provides a broad range of consumer products for home activities such as food preparation, cooking, cleaning, and organization; as well as products for outdoor and on-the-go activities such as hydration, food storage, backpacks, and travel gear, and The Beauty and Wellness segment provides beauty and wellness products including mass and prestige market beauty appliances, prestige market liquid-based hair and personal care products, and wellness devices including thermometers, water and air filtration systems, humidifiers, and fans.

Share on Social Networks: